GlassScriptPhysician profile
Suzanne M Jiloca
NPI 1598993800
$762.06
in general payments reported to CMS, 2019-2025
15 companies · $41.99 in 2025
The $41.99 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.30 · 2020: $11.44 · 2021: $139 · 2022: $121 · 2023: $115 · 2024: $254 · 2025: $41.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $170.24 | 2023-2024 | Enseal, Stratafix, Enseal X1 |
| Abbvie INC. | $135.39 | 2019-2022 | |
| Astellas Pharma US INC | $92.48 | 2021-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $61.58 | 2021-2025 | |
| Allergan, INC. | $49.02 | 2019 | |
| Medicem INC. | $48.85 | 2021 | |
| Organon LLC | $47.60 | 2023-2024 | Nexplanon |
| Medtronic, INC. | $31.66 | 2022 | |
| Axonics, INC. | $22.27 | 2022 | |
| Sage Therapeutics, LLC | $20.31 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $19.49 | 2024 | Gardasil, Gardasil 9 |
| Exact Sciences Corporation | $19.02 | 2024 | Cologuard Collection Kit |
| Coopersurgical, INC. | $17.89 | 2024 | Endosee |
| Pfizer INC. | $14.82 | 2024 | |
| Avion Pharmaceuticals | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Jiloca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.